The European Commission on Friday approved AstraZeneca Plc (NASDAQ:AZN) and Daiichi Sankyo's (OTC:DSKNY) Enhertu (trastuzumab ...
Several pharma CEOs met with Chinese President Xi Jinping in Beijing. President Donald Trump's reciprocal tariffs have mostly ...
Cambridge: AstraZeneca has announced that the Company's Imfinzi (durvalumab) in combination with chemotherapy has been ...
Approval based on AEGEAN Phase III trial results which showed a 32% reduction in the risk of recurrence, progression or death vs. neoadjuvant chemotherapy alone ...
The Cambridge, England-based pharmaceuticals firm said Enhertu, or trastuzumab deruxtecan, has been approved in the EU as a therapy for adult patients with unresectable or metastatic hormone ...
MedPage Today on MSN17h
Policy Fallout Continues; Rise in Lung Cancer Screening; Going Public With DenialsAn artificial intelligence-aided program accurately predicted 5-year survival for early breast cancer on the basis of a tumor's location. (JCO Clinical Cancer Informatics) Actor D ...
Daughter says co-founder of health and beauty chain Phillip Wain in Hong Kong, Southeast Asia, died on March 14 at his home ...
Cuts to the CDC and FDA, experts say, could reverse hugely successful campaigns to cut cigarette smoking rates and curb teen vaping.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback